A potent, reversible inhibitor of caspase-3 and caspase-7 (Kis = 0.23 and 1.6 nM, respectively) also inhibits other caspases (Kis = 18, 1710, 132, 205, 31, 0.92, 60, and 12 nM for caspases-1, -2, -4, -5, -6, -8, -9, and -10, respectively).
A potent, reversible inhibitor of caspase-3 and caspase-7 (Kis = 0.23 and 1.6 nM, respectively) also inhibits other caspases (Kis = 18, 1710, 132, 205, 31, 0.92, 60, and 12 nM for caspases-1, -2, -4, -5, -6, -8, -9, and -10, respectively).
An unsaturated fatty acid found in royal jelly produced from honeybees demonstrates longevity-promoting effects in C. elegans, down regulates matrix metalloproteinases (MMPs) in rheumatoid arthritis, inhibits VEGF-induced angiogenesis in HUVECs,
An unsaturated fatty acid found in royal jelly produced from honeybees demonstrates longevity-promoting effects in C. elegans, down regulates matrix metalloproteinases (MMPs) in rheumatoid arthritis, inhibits VEGF-induced angiogenesis in HUVECs,
A potent, reversible inhibitor of caspase-3 and caspase-7 (Kis = 0.23 and 1.6 nM, respectively) also inhibits other caspases (Kis = 18, 1710, 132, 205, 31, 0.92, 60, and 12 nM for caspases-1, -2, -4, -5, -6, -8, -9, and -10, respectively).
A potent, reversible inhibitor of caspase-3 and caspase-7 (Kis = 0.23 and 1.6 nM, respectively) also inhibits other caspases (Kis = 18, 1710, 132, 205, 31, 0.92, 60, and 12 nM for caspases-1, -2, -4, -5, -6, -8, -9, and -10, respectively).
A natural flavanone glycoside formed from naringenin and neohesperidose undergoes extensive metabolism in the liver, giving rise to naringenin and other bioactive metabolites that have anti-oxidant, anti-inflammatory, and anti-apoptotic effects.
A natural flavanone glycoside formed from naringenin and neohesperidose undergoes extensive metabolism in the liver, giving rise to naringenin and other bioactive metabolites that have anti-oxidant, anti-inflammatory, and anti-apoptotic effects.
An inhibitor of hGIIA sPLA2 (IC<sub>50</sub> = 9 nM), as well as mouse GIIA (mGIIA), hGIIE, mGIIE, hGX, and mGX PLA2s, but poorly inhibits other PLA2 enzymes inhibits serum sPLA2 activity in transgenic mice expressing human sPLA2 when given either
An inhibitor of hGIIA sPLA2 (IC<sub>50</sub> = 9 nM), as well as mouse GIIA (mGIIA), hGIIE, mGIIE, hGX, and mGX PLA2s, but poorly inhibits other PLA2 enzymes inhibits serum sPLA2 activity in transgenic mice expressing human sPLA2 when given either
A selective IDO1 inhibitor (IC<sub>50</sub>s = 67 and 19 nM for human IDO in enzymatic activity and HeLa cell assays, respectively) decreases kynurenine levels in plasma and dose-dependently reduces the growth of GM-CSF-secreting B16 tumor
A selective IDO1 inhibitor (IC<sub>50</sub>s = 67 and 19 nM for human IDO in enzymatic activity and HeLa cell assays, respectively) decreases kynurenine levels in plasma and dose-dependently reduces the growth of GM-CSF-secreting B16 tumor
PLC catalyzes the hydrolysis of phosphatidyl inositol (4,5) bisphosphate (PIP2) on the cytoplasmic side of the cell membrane to yield diacylglycerol and inositol-1,4,5-triphosphate (IP3). This reaction initiates a well-known signal transduction
PLC catalyzes the hydrolysis of phosphatidyl inositol (4,5) bisphosphate (PIP2) on the cytoplasmic side of the cell membrane to yield diacylglycerol and inositol-1,4,5-triphosphate (IP3). This reaction initiates a well-known signal transduction